AlgoNomics > Home

01/02/2008
AlgoNomics to enter research collaboration with Genmab.
more...

17/12/2007
AlgoNomics appoints Philippe Stas as CEO.
more...

Dec 13 2007
Maxygen to access Epibase® technology.
more...

Nov 19 2007
4-Antibody to access Epibase® technology.
more...

Oct 22 2007
Crucell to access Epibase® technology.
more...

AlgoNomics will present at CHI
" Bio-IT World" Boston (USA), Apr 28-30 2008

AlgoNomics will present at CHI
" Protein Engineering Summit" Boston (USA), Apr 28-May 2 2008

AlgoNomics will present at the IIR
" Immunogenicity for biotherapeutics" McLean(VA, USA), May 19-21 2008

Meet AlgoNomics at the
" Bio Convention" San Diego (USA), Jun 17-20 2008

Epibase® is our premier product for T-helper and CTL epitope discovery.

AlgoNomics provides structural bioinformatics services to develop rationally designed therapeutics in the broad field of immunotherapy.


	Copyright 2002-2005, AlgoNomics all rights reserved Contact us at info@algonomics.com or call +32 (0)9 241.11.00 Last updated: January 15, 2007 - made by mediamind.be